Inside Waters Corp’s Upcoming Third Quarter Earnings Release

S&P 500 (NYSE:SPY) component Waters Corp (NYSE:WAT) will unveil its latest earnings on Tuesday, October 25, 2011. Waters is an analytical instrument manufacturer that designs, manufactures, sells and services liquid chromatography, ultra performance liquid chromatography, mass spectrometry instrument systems, and support products.

Waters Corp Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for profit of $1.13 per share, a rise of 15.3% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $1.15. Between one and three months ago, the average estimate moved down. It has been unchanged at $1.13 during the last month. For the year, analysts are projecting net income of $4.80 per share, a rise of 17.4% from last year.

Past Earnings Performance: The company missed estimates last quarter after beating forecasts in the prior two. In the second quarter, the company reported profit of $1.08 per share versus a mean estimate of net income of $1.14 per share. In the first quarter, the company beat estimates by 8 cents.

Investing Insights: has a Stock Chart Technical Analysts Dream About.

Wall St. Revenue Expectations: Analysts are projecting a rise of 12.6% in revenue from the year-earlier quarter to $451.6 million.

Analyst Ratings: 10 out of 16 analysts surveyed (62.5%) have a buy rating on Waters.. This is below the mean analyst rating of 10 competitors, which average 68.9% buy ratings. Over the past 90 days, the average rating for the stock has moved up from hold to moderate buy.

A Look Back: In the second quarter, profit rose 17.8% to $100.1 million ($1.07 a share) from $84.9 million (90 cents a share) the year earlier, but fell short analyst expectations. Revenue rose 14.5% to $447.6 million from $391.1 million.

Key Stats:

The company has seen net income rise in three straight quarters. Net income rose 25.1% in the first quarter and 21.6% in the fourth quarter of the last fiscal year.

Revenue has risen the past four quarters. Revenue rose 16.3% in the first quarter from the year earlier, climbed 12.8% in the fourth quarter of the last fiscal year from the year-ago quarter and 7.2% in the third quarter of the last fiscal year.

Competitors to Watch: Bruker Corporation (NASDAQ:BRKR), Dionex Corporation (NASDAQ:DNEX), Transgenomic, Inc. (TBIO), Beckman Coulter, Inc. (NYSE:BEC), PerkinElmer, Inc. (NYSE:PKI), Thermo Fisher Scientific Inc. (NYSE:TMO), Bio-Rad Laboratories, Inc. (NYSE:BIO), Harvard Bioscience, Inc. (NASDAQ:HBIO), Cepheid (NASDAQ:CPHD), and Mettler-Toledo Intl. Inc. (NYSE:MTD).

Stock Price Performance: During July 26, 2011 to October 19, 2011, the stock price had fallen $13.24 (-14.8%) from $89.25 to $76.01. The stock price saw one of its best stretches over the last year between March 23, 2011 and April 5, 2011 when shares rose for 10-straight days, rising 6.7% (+$5.65) over that span. It saw one of its worst periods between December 20, 2010 and December 31, 2010 when shares fell for nine-straight days, falling 3.4% (-$2.76) over that span. Shares are down $1.70 (-2.2%) year to date.

(Source: Xignite Financials)

Investing Insights: has a Stock Chart Technical Analysts Dream About.